We characterized spontaneous immune responses against optimized 38-mere arginase-1-derived peptide epitope in cancer patients and healthy donors using ex vivo and in vitro IFNγ ELISPOT and intracellular staining for IFNγ and TNFα. This evidence concerns the gene IFNG and cancer.